medical information
Delivering accurate information for patient health and safety.



Comprehensive Medical Information Services
With strategically positioned and seamlessly integrated contact centers around the world, we provide customizable medical information services to meet the needs of companies of all sizes. Whether you need adverse event intake and follow-up, medical writing and content management solutions, promotional review, or other extended medical information services, our team of medical information specialists have the knowledge and experience to effectively support your needs.
Medical Information Solutions:
Our innovative, market-leading technologies, and 24/7/365 contact centers allow us to provide best-in-class medical information services.
Global Contact Center Support
ProPharma's Medical Information (MI) Contact Center services “follow the sun,” providing 24-hour services for pharmaceutical companies. Our team is comprised of experienced healthcare professionals (HCPs) and life science graduates who act as an extension of your team, communicating essential product information in the areas of drug/device information and product safety.

Global 24/7/365 Contact Center Support
We offer 24/7/365 contact center support for first-line, second-line, and triage MI in both dedicated and shared models. We support your patients and your organization with expert handling of all MI requests, adverse event (AE) intake, and product quality complaint (PQC) intake.
Bilingual Native Speakers
Our team of highly trained MI specialists includes bilingual native speakers in more than 35 languages. With 8 strategically positioned and globally integrated contact centers around the world, we can respond to medical inquiries in a manner that is not only consistent with product labeling and regulatory guidance, but also consistent with local evidence, culture, and communication styles.
After Hours Services
As a "follow the sun" provider of MI services, we operate at full capacity beyond normal business hours providing you with around the clock, global support services.
Adverse Event Intake and Follow-up Services
ProPharma’s Medical Information (MI) team is trained on Adverse Event (AE) intake since onboarding as part of MI processing. We ensure that every AE is collected for patients’ safety, customer journey, and compliance at every contact center exchange and sent to the designated pharmacovigilance (PV) department. For a seamless experience, ProPharma offers comprehensive AE processing and reporting through our dedicated PV team to supplement or fully outsource your existing PV function.
Comprehensive AE Intake
Our skilled specialists follow established global processes and guidelines to obtain timely, accurate, and comprehensive AE information. ProPharma conducts refresher training, regular updates, and quality monitoring to ensure that every AE is detected and delivered to PV within 1 business day. Our AE collection forms can be customized for your needs in our fully validated database and our specialists are experienced with various client databases and AE forms.

Adverse Event Follow-up
Our experienced MI team is fully equipped to execute outbound follow-up communication and collect additional data that was not available at initial intake, which lessens the burden on your pharmacovigilance department.
Seamless Integration to Pharmacovigilance
All AE records automatically migrate from MI to the PV database within ProPharma, and you can review and monitor all cases from beginning to end in a single-point access 24/7. ProPharma can also integrate (E2B) with your PV database for the seamless and timely transfer of AE records.
Product Complaint Intake and Follow-Up Services
ProPharma’s MI team is trained on Product Quality Complaint (PQC) intake since onboarding as part of MI processing. We ensure that every PQC is collected for patients’ safety, customer journey, and compliance at every contact center exchange and sent to the designated quality department. We are dedicated to supporting your customers and patients by handling every PQC and your company’s reputation with empathy and care.
Comprehensive PQC Intake
As your trusted MI partner, our highly trained specialists follow established global processes and guidelines for handling PQC events, to meet regulatory reporting requirements as well as your company’s own internal quality and manufacturing standards. ProPharma conducts refresher training, regular updates, and quality monitoring to ensure that every PQC is detected and delivered to the quality department within 1 business day. Our PQC collection forms can be customized for your needs in our fully validated database and our specialists are experienced with various client databases and PQC forms.
Global Quality Serialization and Product Surety
We work collaboratively with our clients to offer centralized solutions for Global Quality Serialization and Product Surety (Level 5 Alerts), compliant with EU FMD and US DSCSA. Our skilled staff have extensive experience with the alerts that are generated within the European Medicines Verification System (EMVS), detected by a national system, which are escalated to other stakeholders, including National Competent Authorities (NCAs) as they are generated. Our experienced team are also fully equipped to follow the process requirements for triage, follow-up, and closure of any Product Quality Serialization Verification requests. The intent of the requirements for reporting Level 5 Alerts set out in the Falsified Medicines Directive is to protect patient safety. Therefore, we ensure that our approach is pragmatic, effective, efficient, and solely focused on you and your patients.
Explore DSCSA Compliance and Serialization Services
Product Retrieval
Our specialists communicate product retrieval instructions as well as company policies regarding product replacement or reimbursement requests. We can also create a product retrieval kit and logistics to provide to the customers to return the products to your quality department or manufacturer.
Talk to an ExpertPatient Support Programs
ProPharma partners closely with internal teams to support our clients’ customers and patients to provide first-in-class global Patient Support Programs. Our diverse team of global contact centers and field partners support patients and healthcare professionals worldwide in obtaining, understanding, and adhering to therapies for a well-rounded customer journey.
Patient Assistance
ProPharma helps patients initiate and adhere to therapy by attenuating the financial burden, facilitating reimbursement, and providing outreach and support. We support both specialist-to-patient interaction and digital offerings to buttress the need of diverse patient demographics. Our customized solution can increase therapy adoption, patient engagement, and adherence, helping your goal to improve patients’ health.
Patient Education
ProPharma’s subject matter experts (SMEs) in the breadth of therapeutic areas aid patients with comprehending the disease state and medication or device use. We create and provide materials that translate complex information into easy to digest content with visuals to supplement the compassionate interaction with the specialists.
Provider Support
ProPharma supplies providers with materials for patient education, such as handouts and mock devices, to better serve their patients. We also provide helpful information to guide patients to therapy decisions by overcoming access or financial barriers. ProPharma is dedicated to ensuring that your customers are supported in all avenues.
Medical Communications, Content Management & Translation
Medical writing is an essential part of clinical research, which requires expert knowledge to analyze and prepare complex regulatory documents.
ProPharma is a global leader in pharmaceutical consulting with over 35 years of experience, and our medical writing team has the expertise to assist with the development of your product. Our team of writers, editors, and quality reviewers knows what it takes to produce clear, concise text for your clinical, scientific, and regulatory needs.
No matter where you are in the development process, we can act as an extension of your team to support your initiatives and achieve successful outcomes.
Standard Document Creation
Our query management services include developing and updating libraries of standard response documents, sourcing and supplying clinical papers, and writing safety summaries. Our team of bilingual, native-speaking medical professionals can create or translate key standard documents in more than 35 local languages.
Custom Response and Content Management
Clients turn to ProPharma for quality and affordable custom response documents, delivered in a timely manner. Our team has experience in all therapeutic areas, with backgrounds in both the life science industry and academia. We provide a full range of content services, including literature research, writing custom response documents, and adapting documentation for use in other geographies.
Response Document Maintenance
We understand the importance of keeping your documents up to date with strict version control to provide the most accurate responses to inquiries. We work with your teams to take this burden off your hands, with efficient document management processes that our clients trust and rely on.
Translation and Localization Services
We support your internal teams by creating new standard response documents, generating custom responses, and translating existing global and/or regional documents into one of over 35 supported languages. Our knowledgeable staff of bilingual native speakers leverage their extensive medical and communications experience to create effective documents that are consistent with local evidence, culture, and communication styles.
Medical Writing Services
From general guidance on strategy and formatting to specific projects like submissions and assessments — we can support your organization and adapt to changing needs throughout the development process.
Clinical and Nonclinical Medical Writing
- Benefit-risk assessments and Risk Management Plans (RMPs)
- Biologics License Applications (BLAs)
- Clinical Study Reports (CSRs) and narratives
- New Drug Applications (NDAs) (505)(b)(1) and 505(b)(2) submissions
- NDAs Modules 1-5
- Regulatory responses to questions
- Investigational New Drug Applications (INDs) and Investigational Device Exemption Applications (IDEs)
- Clinical Trials Disclosure (CTD) and authoring of plain language documents
- Chemistry, Manufacturing, and Controls (CMC) materials
- Drug Safety Update Reports (DSURs), Periodic Safety Update Reports (PSURs), and Periodic Benefit-Risk Evaluation Reports (PBRERs)
- General investigational plans
- Informed consent forms
- Investigator’s Brochure (IB)
- Medical device Clinical Evaluation Reports (CERs)
- Pediatric Investigation Plans (PIPs) and Pediatric Study Plans (PSPs)
- Lifecycle management
- Protocols and amendments
- Orphan Drug Designation (ODD)/Breakthrough Designation
- Pre-meeting packages (PMPs)/briefing packages
- Ethnic Sensitivity Reports
- Immunogenicity Reports
Project Support
- Compilation, hyperlinking, and publishing
- Comprehensive project management
- Content editing and proofreading: Including a QC review of data against text and source documents
- Style guide and template creation
- Literature searches, analysis, reference libraries, and citations
- Standard operating procedure (SOP) development
- Build figures and populate tables
Publications
- Abstracts, Manuscripts, and White Papers
- Continuing Medical Educations (CME) program planning
- Publication strategy
Medical Information Experts

Rajul Jain
President
Medical Information

David Bezick
Director
Medical Information

Hannah Hunter
Director
Medical Information

Katie Tonge
Director
Medical Information

Leanne Shaw
Senior Director
Medical Information

Valerie Huh
Associate Director
Global Innovation

Victoria Evans
Director
Medical Information
News & Insights

September 27, 2023
The Impact of a US Government Shutdown on the Food and Drug Administration
U.S. lawmakers are actively attempting to negotiate a deal to prevent a government shutdown on October 1, 2023. Along with many other government agencies, the ability of the Food and Drug...

September 25, 2023
DSCSA Requirements and Responsibilities for Drug Manufacturers (Sponsor vs CMO)
With the final deadline for complete compliance with the FDA's Drug Supply Chain Security Act (DSCSA) looming on the horizon, where do you find your organization? Although the FDA has now issued two...

September 27, 2023
ProPharma Appoints Alena Hammond as Global Head of Clinical Operations
Raleigh, NC, September 27, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...

September 13, 2023
ProPharma Introduces ClinCHAT, a Solution to Unleash the Power of Real-World Evidence with Conversational AI
Raleigh, NC, September 13, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...

August 30, 2023
ProPharma Expands Regulatory Sciences Team in the Japan and Asia-Pacific Region with Addition of Neama Baho
RALEIGH, NC, August 30, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...

May 3, 2022
ProPharma Group Named Top 10 CRO 2022 by Pharma Tech Outlook
ProPharma Group Named Top 10 CRO 2022 by Pharma Tech Outlook A Customer-Centric Approach to Clinical Research Solutions ProPharma Group is honored to be named Top 10 CRO 2022 by Pharma Tech Outlook...

April 21, 2022
ProPharma Group Named Best Pharmaceutical Regulatory & Compliance Consultancy: 2022 Corporate Excellence Awards
ProPharma Group Named Best Pharmaceutical Regulatory & Compliance Consultancy: 2022 Corporate Excellence Awards: ProPharma Group is honored to be awarded “Best Pharmaceutical Regulatory & Compliance...

June 10, 2022
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

August 31, 2022
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma Group offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma Group’s Compliance and Quality team completed the...
News & Insights

September 27, 2023
ProPharma Appoints Alena Hammond as Global Head of Clinical Operations
Raleigh, NC, September 27, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...

September 13, 2023
ProPharma Introduces ClinCHAT, a Solution to Unleash the Power of Real-World Evidence with Conversational AI
Raleigh, NC, September 13, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...

August 30, 2023
ProPharma Expands Regulatory Sciences Team in the Japan and Asia-Pacific Region with Addition of Neama Baho
RALEIGH, NC, August 30, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...

April 21, 2022
ProPharma Group Named Best Pharmaceutical Regulatory & Compliance Consultancy: 2022 Corporate Excellence Awards
ProPharma Group Named Best Pharmaceutical Regulatory & Compliance Consultancy: 2022 Corporate Excellence Awards: ProPharma Group is honored to be awarded “Best Pharmaceutical Regulatory & Compliance...

Sep 27, 2023 11:57:42 AM
The Impact of a US Government Shutdown on the Food and Drug Administration
U.S. lawmakers are actively attempting to negotiate a deal to prevent a government shutdown on October 1, 2023. Along with many other government agencies, the ability of the Food and Drug...

Sep 25, 2023 4:59:00 PM
DSCSA Requirements and Responsibilities for Drug Manufacturers (Sponsor vs CMO)
With the final deadline for complete compliance with the FDA's Drug Supply Chain Security Act (DSCSA) looming on the horizon, where do you find your organization? Although the FDA has now issued two...

October 14, 2021
Accelerate European Market Access with Compliant and Comprehensive MAA Submission
Preparedness for Marketing Authorization Application (MAA) approval ensures an efficient application process and follow-up. Placing a medicinal product in the European market requires a license for...

March 18, 2022
Outsourcing QA - Reduce Time and Expense While Meeting Critical Requirements
There is a tendency for VPCs to rely solely on the QC/QA units within their outsourced CMO to perform quality functions. However, the sponsor organization has the ultimate responsibility for product...

October 14, 2021
Dedicated Project Manager Directs Regulatory Activities Throughout European Economic Area
Learn how a single point of contact oversaw local regulatory affairs activities across all 31 countries of the EEA. You’re developing a drug, biologic, or medical device product. There are a lot of...

September 1, 2022
Webinar: AI-Powered MI Contact Centers: Key Considerations for a Scalable & Global Medical Information Capability
Today's Medical Information (MI) industry is being driven by evolving customer behavior requiring a more rapid, omnichannel, and digital response to customer needs. The expectation for higher...

October 14, 2021
Ensure Successful Acquisitions with Complete and Accurate Regulatory Due Diligence
Ensure you have as much information as possible to thoroughly evaluate the potential investment when acquiring a company or product. When considering the acquisition of a new company or product, it...

October 14, 2021
Ensure Successful Batch Release, Regulatory Compliance with Experienced Qualified Persons
Streamlining a CMO’s manufacturing process helped ensure GMP compliance for EU batch release and USA inspection readiness. A contract manufacturing organization (CMO) needs to have a reliable quality...

September 27, 2023
How a Two-Part NDA Regulatory Strategy Resulted in Submission Success
Developing a New Drug Application (NDA) for submission to the FDA is an extremely complex process and one that can present challenges to even the most seasoned professionals. From ensuring you have...

October 4, 2021
How to Minimize Overdue Deviations: A Multi-Site Process Improvement Approach
A global biopharmaceutical client with multiple sites operating under a Warning Letter from the U.S. Food and Drug Administration (FDA) needed significant cross-functional support to meet remediation...

October 14, 2021
Identify At-Risk Drug Products and Ensure Compliance Before Nitrosamines Deadline
Risk evaluation of products containing chemically synthesized APIs must be done to assess adherence to nitrosamine regulations. Marketing Authorization Holders (MAHs) must perform a risk evaluation...

October 4, 2021
Increased Visibility for Senior Management with Custom PMO Design, Implementation
Time. Regardless of company size and the number of products in your portfolio, time is one thing we could all use more of. However, the more projects you have in your portfolio, the more stretched...

October 14, 2021
Initiating Enrollment for Accelerated COVID-19 Treatment Studies in 6 Days
In May 2020, as the FDA released new guidelines to accelerate the development of novel COVID-19 therapeutics and vaccines, our Clinical Services experts were asked to provide independent Data Safety...

October 14, 2021
MICC Overflow Solution Was Successfully Deployed and Preserved Customer Satisfaction
A routine safety letter to healthcare professionals (HCPs) was misinterpreted by recipients, causing a “recall-like” crisis event for a multinational pharmaceutical client. When a routine safety...

September 27, 2023
Insider Talks - The Journey of ATMPs From the Discovery to Routine GMP Real Life
In the competitive and fast-moving Cell and Gene Therapy (CGT) field, developers face a range of scientific, technical, and regulatory challenges that can quickly become overwhelming and costly. In...

May 19, 2022
Insider Talks - Tips to Adapt to Today’s Auditing Environment, an Auditor’s Perspective
As businesses face the shared global challenges of adapting to new operating models triggered by the recent pandemic, regulated drug and device sponsors, marketing authorization holders, and...

March 25, 2022
Insider Talks - To Decentralize or Not to Decentralize … That is the Question
Having a decentralized approach is critical to ensuring continuity in the face of disaster, and important in meeting your overall enrollment goals while increasing patient diversity. Join us for our...

October 14, 2021
Secure Timely Product Launch by Ensuring GDP Compliance Across Europe
Our client was in the phase of submitting a Marketing Authorization Application (MAA) in the EU and needed to apply for a Wholesale Distribution Authorization (WDA). After application and approval of...

October 14, 2021
Transfer and Manage Clinical Data Provided by Multiple Third-Party Vendors
Managing and sharing large amounts of clinical data provided by a team of ten plus vendors is extremely challenging and requires meticulous attention to detail and expert-level project management to...

October 14, 2021
Understanding Clinical Trial Requirements for Medical Device Label Extensions
After you have developed an FDA-regulated product and obtained marketing approval, you may think your job is done. However, after all the time, effort, money, and so much more that goes into product...

September 27, 2023
What You Need to Know About Regulatory Programs for Expedited Approval
Differentiating between the FDA and EMA's expedited approval pathways can be tricky. Learn the similarities and differences between them to help determine the best option(s) for your product. The...

October 17, 2021
Outsourcing of Medical Information Content Creation: Experience of 100 Clients
The time and effort required to write, review, edit, approve, maintain, distribute, and update Medical Information (MI) documents while retaining an auditable record of the search strategy is a great...

October 4, 2021
Outsourcing Medical Information Services: When to Consider a Dedicated Resource
Outsourcing Medical Information (MI) services can be an effective solution for ensuring the provision of MI services to HCPs and consumers globally. The most cost-effective model for the provision of...

May 3, 2023
Improve Quality & Consistency by Leveraging AI for Trial Master File Classification
Improve Quality and Consistency by Leveraging AI for Trial Master File Classification The whitepaper "Improve Quality and Consistency by Leveraging AI for Trial Master File Classification" addresses...

Complex Needs Require Custom Solutions
ProPharma builds solutions at the intersection of innovation and flexibility. We’re here to offer a custom alternative that fits your unique needs. Standout solutions scaled to your size.